Renal denervation technologies, which are already the focus of much clinical attention for the potential to treat high blood pressure without drugs, may have a bonus side-effect in keeping the heart in check, according to researchers.
American College of Cardiology Conference (ACC)
ACC.13 Roundup: A big week for Medtronic’s Symplicity high blood pressure device
Transcatheter mitral valves are going to the dogs
The field of transcatheter mitral valve repair may move more quickly in pet populations than it does in human medicine, according to a presentation during this week’s American College of Cardiology conference in San Francisco.
Researchers are hard at work on a technology, called MitralSeal, they they hope to bring to market to treat mitral valve regurgitation in dogs.
TAVI: Sapien going strong at 3 years, but leak risk remains “overwhelmingly” higher
Updated March 19, 2013, at 11:30 a.m. to reflect that the quote in paragraph 6 came from an ACC press release, not an Edwards press release.
Profile of an FDA critic: Q&A with patient safety advocate Dr. Robert Hauser
Veteran cardiologist Dr. Robert Hauser is eager for change, even if he has to go straight to Capitol Hill himself to make it happen.
The patient safety advocate and vocal critic of the FDA announced at this year’s American College of Cardiology conference that he’s working on a proposal to fundamentally change the way federal regulators monitor medical devices and drugs once they hit the market.
ACC defends cancellation as docs lament missing Boston Scientific presentation | MassDevice.com On Call
MASSDEVICE ON CALL — The embargo breach that got Boston Scientific’s (NYSE:BSX) PREVAIL clinical trial results pulled from the lineup at the American College of Cardiology conference this weekend was "an honest mistake," according to the company, but conference organizers don’t regret canceling the presentation.
Hauser’s FDA Rx: The FDA needs an NTSB
Dr. Robert Hauser hopes to push a major change at the FDA, looking to shift the monitoring of medical devices and drugs that are already on the market from the FDA to an independent entity.
Hauser, a long-time patient safety advocate and vocal FDA critic, is aiming to sell Capitol Hill on a new structure for the U.S. healthcare regulation system akin to how the nation deals with transportation safety, he told MassDevice.com in an exclusive interview.
Early results “encouraging” for Edwards’ redesigned Sapien XT valve
Boston Scientific apologizes for embargo breach that got its Watchman trial pulled from conference
Updated March 9, 2013, at 8:30 p.m. PST with comment, slides from Boston Scientific.
The PREVAIL flail: A contrarian view
"The good thing about bad news – it sells."
Do hybrid cars interfere with cardiac implants? Apparently not, study finds
In the 1st study of its kind to examine the interaction between hybrid cars and implantable cardiac devices, researchers found that the electromagnetic waves generated by the green vehicles don’t pose a threat.
"Hybrid cards do not generated clinically relevant amounts of [electromagnetic interference]," according to a team of researchers from the Mayo Clinic of Arizona. "It is safe for patients with ICD to interact with hybrid cars."